Purdue and Amneal OxyContin clash ends

15-08-2018

Purdue and Amneal OxyContin clash ends

sprng23 / iStockphoto.com

A patent dispute over a generic version of Purdue Pharma’s drug OxyContin (oxycodone), which is used to treat moderate to severe pain, has come to an end.


Purdue Pharma, Amneal, OxyContin, ANDA, FDA, patent, patent infringement, oxycodone, dismissal

LSIPR